Congenital Hyperinsulinism clinical trials at UCSF
1 research study open to eligible people
Showing trials for
18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism
open to eligible people ages up to 18 years
The goal of this project is to determine the role of FDOPA/PET as a pre-operative diagnostic imaging procedure for differentiating focal and diffuse forms of congenital hyperinsulinism and locating focal lesions in the pancreas to guide surgical resection.
San Francisco, California
Our lead scientists for Congenital Hyperinsulinism research studies include Miguel Hernandez Pampaloni, MD, PhD.